v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05043350 |
Full text link
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
2021-09-14 |
Recruitment status
Last imported at : Aug. 27, 2023, 8 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : Aug. 27, 2023, 8 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: adult patients (>18 years old). confirmed covid-19 infection with pcr. moderate covid patients who with sp02 <92 % ct chest infiltration more than 50 % presented to the hospital within 24 to 48 hours cbc (wbcs may be normal or high or low with lymphocytopenia is present, decreased hemoglobin, neutrophilia with neutrophil/lymphocyte ratio > 3.1) |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
hepatic or renal failure: (alanine transaminase or aspartate transaminase >3 times above the normal limit) history or evidence of long qt segment on electrocardiogram, pregnancy or breast-feeding mother patient on mechanical ventilator. patient who received vaccine. patients receiving antidepressants, opioids, (e.g., anticonvulsants, clonazepam). |
Number of arms
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Ain Shams University |
Inclusion age min
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
2 |
Inclusion age max
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Aug. 27, 2023, 8 a.m. Source : ClinicalTrials.gov |
Egypt |
Type of patients
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Severe disease at enrollment |
Severity scale
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
6: Severe disease at enrollment |
Total sample size
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
214 |
primary outcome
Last imported at : Aug. 27, 2023, 8 a.m. Source : ClinicalTrials.gov |
Assessment of number of patients who will need Mechanical ventillation;Assessment of the number of patients who will need vasopressor due to progression to shock |
Notes
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
Phase 2/Phase 3 |
Arms
Last imported at : Sept. 16, 2021, 5 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 503, "treatment_name": "Famotidine", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1910, "treatment_name": "Famotidine+loratidine", "treatment_type": "Others pharmacological treatment+respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}] |